Emerging new clinical applications for palifermin: beyond its use in oral mucositis and graft versus host disease

Emerging new clinical applications for palifermin: beyond its use in oral mucositis and graft versus host disease Letter (1688) Total Article Views Authors: Kapoor S Published Date June 2012 Volume 2012:6 Pages 135 - 136 DOI: http://dx.doi.org/10.2147/BTT.S31959 Received: 19 March 2012 Accepted: 20 March 2012 Published: 07 June 2012 Shailendra Kapoor Richmond, VA, USA To the editor I read with great interest the recent article by Barasch et al in a recent issue of your journal. The article is highly thought-provoking. Interestingly, the past few years have seen the emergence of a number of novel clinical applications of palifermin, in addition to its use in oral mucositis and graft versus host disease. Post to: Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter Readers of this article also read: Pediatric ulcerative colitis: current treatment approaches including role of infliximab The effect of erythropoietin on normal and neoplastic cells Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study Hepatocellular carcinoma: natural history, current management, and emerging tools Clinical utility of targeted treatments in the management of epithelial ovarian cancer New developments in the management of hepatitis C virus infection: focus on boceprevir The role of epigenetic mechanisms and processes in autoimmune disorders Lebrikizumab in the personalized management of asthma Epigenetics and stroke risk – beyond the static DNA code Clofilium inhibits Slick and Slack potassium channels